Lungen Lu

656 total citations
27 papers, 315 citations indexed

About

Lungen Lu is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Lungen Lu has authored 27 papers receiving a total of 315 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hepatology, 13 papers in Epidemiology and 7 papers in Surgery. Recurrent topics in Lungen Lu's work include Liver Disease Diagnosis and Treatment (13 papers), Liver physiology and pathology (7 papers) and Liver Diseases and Immunity (5 papers). Lungen Lu is often cited by papers focused on Liver Disease Diagnosis and Treatment (13 papers), Liver physiology and pathology (7 papers) and Liver Diseases and Immunity (5 papers). Lungen Lu collaborates with scholars based in China and United States. Lungen Lu's co-authors include Xiaobo Cai, Mingyi Xu, Ying Qu, Binghang Li, Yan Li, Haiyan Ying, Zhenzeng Ma, Liuying Chen, Fei Li and Tianyi Gu and has published in prestigious journals such as Scientific Reports, The FASEB Journal and Biochemical and Biophysical Research Communications.

In The Last Decade

Lungen Lu

26 papers receiving 311 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lungen Lu China	11	138	126	92	84	53	27	315
Fatma El Zahraa Ammar Mohamed Egypt	10	131 0.9×	150 1.2×	76 0.8×	55 0.7×	43 0.8×	23	341
Mao‐xu Ge China	11	157 1.1×	123 1.0×	133 1.4×	46 0.5×	66 1.2×	15	357
Giacomo Batignani Italy	2	233 1.7×	183 1.5×	127 1.4×	77 0.9×	57 1.1×	5	357
Kan Toriguchi Japan	10	132 1.0×	98 0.8×	137 1.5×	69 0.8×	69 1.3×	27	374
Andrea Thüringer Austria	8	117 0.8×	117 0.9×	61 0.7×	100 1.2×	94 1.8×	11	302
Yingmei Tang China	10	127 0.9×	84 0.7×	123 1.3×	64 0.8×	105 2.0×	20	352
Zoe Boyer‐Díaz Spain	7	287 2.1×	218 1.7×	109 1.2×	84 1.0×	25 0.5×	10	426
Yanjun Shen China	10	83 0.6×	148 1.2×	93 1.0×	85 1.0×	80 1.5×	16	362
Liangjun Zhang China	11	180 1.3×	115 0.9×	106 1.2×	80 1.0×	157 3.0×	23	422

Countries citing papers authored by Lungen Lu

Since Specialization

Citations

This map shows the geographic impact of Lungen Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lungen Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lungen Lu more than expected).

Fields of papers citing papers by Lungen Lu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lungen Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lungen Lu. The network helps show where Lungen Lu may publish in the future.

Co-authorship network of co-authors of Lungen Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Lungen Lu. A scholar is included among the top collaborators of Lungen Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lungen Lu. Lungen Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cai, Xiaobo, Wen Xie, Yanbin Wang, et al.. (2025). Hydronidone for the Treatment of Liver Fibrosis Associated with Chronic Hepatitis B: Protocol for a Phase 3 Randomized Trial. Journal of Clinical and Translational Hepatology. 0(0). 0–0. 1 indexed citations

Luo, Xin, et al.. (2025). Ghrelin alleviates liver fibrosis by triggering HSCs ferroptosis via regulating injured hepatocyte‐derived exosomal LncMALAT1 / GPX4 pathway. The FASEB Journal. 39(2). e70297–e70297. 1 indexed citations

Lu, Lungen, et al.. (2024). Current Status of Glucagon-like Peptide-1 Receptor Agonists in Metabolic Dysfunction-associated Steatotic Liver Disease: A Clinical Perspective. Journal of Clinical and Translational Hepatology. 0(0). 0–0. 1 indexed citations

Lu, Lungen, et al.. (2024). Progress in the Management of Patients with Cholestatic Liver Disease: Where Are We and Where Are We Going?. Journal of Clinical and Translational Hepatology. 12(6). 581–588. 4 indexed citations

You, Hong, Weijia Duan, Shuxiang Li, et al.. (2023). Guidelines on the Diagnosis and Management of Primary Biliary Cholangitis (2021). Journal of Clinical and Translational Hepatology. 0(0). 0–0. 13 indexed citations

Guo, Yuecheng, et al.. (2023). Identification of LBH and SPP1 involved in hepatic stellate cell activation during liver fibrogenesis. Human Cell. 36(3). 1054–1067. 3 indexed citations

Xu, Xianjun, Yuecheng Guo, Xin Luo, et al.. (2023). Hydronidone ameliorates liver fibrosis by inhibiting activation of hepatic stellate cells via Smad7‐mediated degradation of TGFβRI. Liver International. 43(11). 2523–2537. 12 indexed citations

Xu, Jingxian, et al.. (2021). An elevated deoxycholic acid level induced by high-fat feeding damages intestinal stem cells by reducing the ileal IL-22. Biochemical and Biophysical Research Communications. 579. 153–160. 19 indexed citations

Chen, Liuying, Tianyi Gu, Binghang Li, et al.. (2019). Delta-like ligand 4/DLL4 regulates the capillarization of liver sinusoidal endothelial cell and liver fibrogenesis. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1866(10). 1663–1675. 51 indexed citations

10.

Cui, Xiaofang, Yan Chen, Chunling Shen, et al.. (2018). Rdh13 deficiency weakens carbon tetrachloride-induced liver injury by regulating Spot14 and Cyp2e1 expression levels. Frontiers of Medicine. 13(1). 104–111. 7 indexed citations

11.

Ying, Haiyan, et al.. (2016). Novel matrine derivative MD-1 attenuates hepatic fibrosis by inhibiting EGFR activation of hepatic stellate cells. Protein & Cell. 7(9). 662–672. 36 indexed citations

12.

Cai, Xiaobo, Feng Li, Heng Liu, et al.. (2016). Cytokeratin19 positive hepatocellular carcinoma is associated with increased peritumoral ductular reaction. Annals of Hepatology. 15(3). 386–393. 7 indexed citations

13.

Zhang, Qidi, Ying Qu, Zhenghong Li, et al.. (2016). Isolation and Culture of Single Cell Types from Rat Liver. Cells Tissues Organs. 201(4). 253–267. 21 indexed citations

14.

Fu, Hualin, Yue Ma, Meng Yang, et al.. (2016). Persisting and Increasing Neutrophil Infiltration Associates with Gastric Carcinogenesis and E-cadherin Downregulation. Scientific Reports. 6(1). 29762–29762. 40 indexed citations

15.

Cai, Xiaobo, Mingyi Xu, Ying Qu, et al.. (2015). Peritumoral ductular reaction is related to nuclear translocation of β-catenin in hepatocellular carcinoma. Biomedicine & Pharmacotherapy. 76. 11–16. 4 indexed citations

16.

Lu, Lungen. (2015). [Consensus on the diagnosis and treatment of cholestasis liver diseases].. PubMed. 23(12). 924–33. 5 indexed citations

17.

Qu, Ying, Lei Zong, Mingyi Xu, Yuwei Dong, & Lungen Lu. (2015). Effects of 18α-glycyrrhizin on TGF-β1/Smad signaling pathway in rats with carbon tetrachloride-induced liver fibrosis.. PubMed. 8(2). 1292–301. 22 indexed citations

18.

Lu, Lungen. (2014). Antiviral Therapy of Liver Cirrhosis Related to Hepatitis B Virus Infection. Journal of Clinical and Translational Hepatology. 2(3). 197–201. 21 indexed citations

19.

Lu, Lungen. (2002). Capsule oxymatrine in the treatment of liver fibrosis in patients with chronic virus hepatitis: A randomized、double blind、placebo-controlled、multicenter clinical study(II). 3 indexed citations

20.

Lu, Lungen. (2002). An experimental study of prophylactic effect of oxymatrine on D-galactosamine-induced rat liver fibrosis. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact